Monitoring Fluid Therapy in Critically Ill Veterinary Patients

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Effective fluid therapy monitoring in critically ill veterinary patients hinges on integrating physical examination findings (heart rate, pulse quality, mucous membrane color, capillary refill time), point-of-care ultrasound, laboratory values (lactate, PCV/TS, electrolytes), and quantitative output measurements (urine output, body weight). No single parameter is sufficient; serial trends are paramount for assessing perfusion improvement, fluid distribution, and potential harm.
• Key physiological parameters to monitor include heart rate and pulse quality for cardiac output and perfusion, blood pressure for perfusion pressure, and urine output (target 1-2 mL/kg/hr in dogs/cats) for renal perfusion and volume status. Serial body weight is a sensitive indicator of net fluid balance, with rapid gains (>5%) suggesting overload.
• Laboratory monitoring provides objective data: declining PCV/TS indicates hemodilution from excessive fluid, while rising lactate signifies ongoing hypoperfusion and guides resuscitation endpoints. Serum creatinine and urea track renal perfusion, and electrolyte monitoring (sodium, potassium) is crucial for guiding fluid type and detecting iatrogenic imbalances.
• Advanced monitoring techniques like central venous pressure (CVP) assess right heart preload, and pulse pressure/stroke volume variation (in mechanically ventilated patients) predict fluid responsiveness. Point-of-care ultrasound can detect pulmonary edema (B-lines) or effusions, indicating fluid overload before radiographic changes.
• Common monitoring errors include mistaking blood pressure for perfusion alone, discontinuing monitoring prematurely, ignoring urinary catheter patency, and over-reliance on single PCV/TS measurements. Species-specific differences, particularly cats' poor tolerance for volume overload, necessitate tailored monitoring frequencies and interpretation.
• Complications of fluid therapy include volume overload (manifesting as weight gain, edema, rising CVP) and hyperchloraemic metabolic acidosis from aggressive 0.9% NaCl administration. Monitoring must detect these before irreversible injury occurs, with corrective actions including switching to balanced crystalloids or adjusting fluid rates.

Fluid therapy is among the most frequent interventions in veterinary critical care, yet its success depends less on the initial prescription than on the quality and frequency of subsequent monitoring. This article provides a structured approach to monitoring fluid therapy in critically ill dogs, cats, horses, and production animals. It is written for veterinary students and early-career clinicians who need a practical framework for selecting monitoring parameters, interpreting trends, and adjusting therapy in real time. The focus is on monitoring, not on fluid selection or dosing formulas.

The core clinical question is straightforward: is the patient's perfusion improving, is the fluid staying where it belongs, and is the therapy causing harm? Answering that question requires integrating physical examination findings, point-of-care ultrasound, laboratory values, and quantitative output measurements. No single parameter is sufficient. The Society of Critical Care Medicine's practice parameters for hemodynamic support of sepsis emphasize that clinicians should define specific goals and endpoints, titrate therapies to those endpoints, and evaluate results continuously by monitoring a combination of global and regional perfusion variables. That principle applies equally to veterinary patients across species.

At a Glance

Physiology of Fluid Compartments and Monitoring Rationale

Fluid therapy alters the distribution of water among the intracellular, interstitial, and intravascular compartments. Crystalloid solutions distribute rapidly across the vascular endothelium, so only a fraction remains intravascular within an hour. Colloids and blood products remain intravascular longer. Monitoring must therefore account for the expected distribution of the fluid being administered and the patient's underlying disease.

The endothelium is not a static barrier. In sepsis, systemic inflammation increases capillary permeability, accelerating the loss of crystalloid from the vascular space and promoting interstitial edema. In conditions such as hypoalbuminemia, reduced oncotic pressure further shifts fluid out of the vasculature. These dynamics explain why a patient may appear adequately perfused immediately after a fluid bolus but deteriorate within an hour as the fluid redistributes. Monitoring intervals must be shorter in patients with suspected endothelial dysfunction.

The concept of fluid responsiveness separates patients who will increase stroke volume with additional fluid from those who will not. A patient on the steep portion of the Frank-Starling curve benefits from volume expansion. A patient on the flat portion does not, and additional fluid only increases the risk of edema. Clinical assessment of fluid responsiveness in veterinary patients relies on surrogate markers such as heart rate changes, pulse quality, blood pressure response, and ultrasound assessment of venous distensibility, though these carry species-specific limitations.

Clinical Examination Parameters

The physical examination remains the foundation of fluid monitoring. Heart rate, pulse quality, mucous membrane color, capillary refill time, skin turgor, and mental status provide a rapid composite assessment of perfusion. In dogs, tachycardia with weak femoral pulses suggests hypovolemia. Cats are more variable, bradycardia can occur in critically ill hypotensive cats, so heart rate alone is unreliable. Horses and ruminants have higher resting heart rates and different normal ranges, and their response to hypovolemia is less predictable.

Serial examination is more valuable than a single assessment. A patient whose heart rate is falling, whose pulse quality is improving, and whose mucous membranes are becoming pinker is responding to therapy. A patient whose parameters are static or worsening despite fluid administration requires reassessment of the fluid plan, consideration of ongoing losses, or evaluation for non-hypovolemic causes of shock such as cardiogenic or distributive processes.

Capillary refill time is a crude but useful indicator of peripheral perfusion. Prolonged CRT with pale mucous membranes suggests vasoconstriction and reduced tissue perfusion. A CRT that normalizes during resuscitation is an early sign of improved microcirculatory flow. Skin turgor reflects interstitial hydration instead of intravascular volume and lags behind acute changes, making it less useful in the first hours of resuscitation.

Blood Pressure Monitoring

Arterial blood pressure is a core monitoring parameter because it reflects the pressure gradient driving tissue perfusion. Hypotension, defined by reference ranges for each species, indicates inadequate perfusion pressure regardless of volume status. Hypertension can also complicate fluid therapy, particularly in patients with renal disease or during over-resuscitation.

Oscillometric devices are noninvasive and widely available but become inaccurate in small patients, hypotensive patients, and patients with arrhythmias. Doppler ultrasound provides systolic pressure estimates and is more reliable in small animals but does not measure diastolic or mean pressures. Direct arterial catheterization provides continuous, accurate pressure measurements and allows arterial blood gas sampling, but it requires technical skill and carries risks of thrombosis and infection. The choice of method depends on patient size, clinical stability, and available equipment.

Blood pressure trends guide fluid titration. A patient with mean arterial pressure below the species-specific target who responds to a fluid bolus with improved pressure is likely volume-responsive. A patient whose pressure does not improve despite adequate volume may require vasopressor support. The sepsis guidelines from the Society of Critical Care Medicine recommend titrating therapies to defined hemodynamic endpoints and reassessing continuously, a framework that applies directly to veterinary resuscitation.

Laboratory Monitoring of Fluid Balance

Serial laboratory assessment provides objective data that complements the physical examination. The frequency of sampling depends on the patient's stability, the rate of fluid administration, and the presence of concurrent disease.

Packed Cell Volume and Total Solids

Packed cell volume (PCV) and total solids (TS) are measured together and interpreted as a pair. In a patient receiving isotonic crystalloids, a progressive decline in both values suggests hemodilution from excessive fluid administration. A rising PCV with stable or falling TS indicates ongoing water loss, such as from polyuria or panting. A rising PCV with rising TS points toward plasma water loss, as seen with severe vomiting or diarrhea. A falling PCV with stable or rising TS raises concern for hemorrhage or red cell destruction.

Serial measurements are more informative than single values. A trend across three or more samples, taken at intervals appropriate to the clinical situation, distinguishes transient fluctuations from sustained shifts. In patients with pre-existing anemia or hypoproteinaemia, the baseline values matter more than the absolute numbers.

Serum Biochemistry

Serum creatinine and urea concentrations track renal perfusion and glomerular filtration. A rising creatinine despite adequate urine output suggests ongoing prerenal azotaemia or developing acute kidney injury. A falling creatinine indicates improved renal perfusion. Creatinine is preferred over urea for monitoring because urea is influenced by hepatic function, gastrointestinal hemorrhage, and dietary protein.

Serum sodium concentration guides the choice of maintenance versus replacement fluids and detects iatrogenic hypernatraemia or hyponatraemia. Rapid correction of dysnatraemia is dangerous, the monitoring interval should be short enough to detect trends before they become extreme. Potassium concentration reflects both total body stores and acid-base status. Hypokalemia develops during diuresis and with prolonged anorexia. Hyperkalemia occurs with oliguric kidney injury, uroabdomen, and reperfusion injury.

Blood glucose should be monitored in any critically ill patient receiving dextrose-containing fluids or with suspected sepsis. Hyperglycemia at the onset of cerebral ischemia worsens neurologic outcome, so glucose control is part of fluid management in patients at risk for ischemic events. Hypoglycemia in neonates and small-breed dogs requires frequent rechecking because clinical signs can develop rapidly.

Acid-Base and Lactate

Venous blood gas analysis provides pH, partial pressure of carbon dioxide, bicarbonate, and base excess. Lactate is measured separately or as part of a blood gas panel. A falling lactate concentration indicates improved tissue perfusion and is one of the earliest laboratory signs of successful resuscitation. A rising or persistently elevated lactate despite fluid therapy suggests ongoing hypoperfusion, inadequate oxygen delivery, or a non-perfusion cause such as hepatic dysfunction.

The Society of Critical Care Medicine guidelines for sepsis recommend titrating therapy to defined end points and monitoring a combination of variables of global and regional perfusion. Lactate clearance is a regional perfusion marker that responds more quickly than blood pressure or urine output. Serial lactate measurements, taken every two to four hours during the initial resuscitation phase, provide a dynamic picture that static parameters cannot.

Urine Output and Fluid Balance Documentation

Accurate measurement of urine output is the single most useful monitoring parameter for guiding fluid therapy in critically ill patients. The target is approximately 1 to 2 mL/kg/hour in dogs and cats, but this range varies with species, hydration status, and the presence of renal disease. In burn patients, urinary output is the primary driver of resuscitation algorithms, with computer-controlled systems using it as the feedback variable to adjust infusion rates.

Indwelling Urinary Catheters

An indwelling urinary catheter with a closed collection system allows hourly measurement. The catheter should be placed using aseptic technique and maintained as a closed system to reduce the risk of ascending infection. In patients with oliguria or anuria, the catheter confirms the absence of urine production instead of bladder rupture. In patients with polyuria, the catheter permits accurate replacement of measured losses.

The decision to place a urinary catheter balances the need for accurate monitoring against the risk of catheter-associated urinary tract infection. Patients expected to require aggressive fluid therapy for more than 12 to 24 hours, patients with hemodynamic instability, and patients receiving diuretics are candidates for catheterization. Patients with coagulopathies or urethral trauma may not be suitable.

Weighing and Intake-Output Charts

Daily body weight is a practical proxy for total body water. A change of 1 kg represents approximately 1 L of fluid. Weighing the patient at the same time each day, on the same scale, and before feeding provides a trend that detects both over-hydration and under-hydration. Rapid weight gain of more than 5% over baseline suggests fluid overload. Rapid weight loss indicates inadequate replacement or ongoing losses.

An intake-output chart records all fluid administered, including intravenous fluids, oral water, and flushes, alongside all measured losses, including urine, vomitus, diarrhea, and drainage from body cavities. The chart is reviewed at least every four hours during the resuscitation phase and every eight to twelve hours during maintenance. Discrepancies between intake and output guide adjustments to the infusion rate.

Advanced Hemodynamic Monitoring

Central Venous Pressure

Central venous pressure (CVP) reflects the relationship between venous return and cardiac function. A CVP below the reference range suggests hypovolemia. A rising CVP during fluid administration indicates that the heart is approaching the limit of its preload reserve. A persistently elevated CVP with falling blood pressure suggests right-sided heart failure or pulmonary hypertension.

CVP measurement requires a central venous catheter and a pressure transducer or water manometer. The measurement is affected by catheter tip position, patient positioning, and intrathoracic pressure. Serial trends are more useful than single values. The American College of Critical Care Medicine sepsis guidelines note that no single hemodynamic variable should be used in isolation, and CVP is best interpreted alongside blood pressure, urine output, and lactate.

Point-of-Care Ultrasound

Focused assessment with sonography for trauma (FAST) and its extensions have moved beyond trauma triage into routine monitoring of critically ill patients. The abdominal FAST examination screens for free fluid in the peritoneal cavity, while the thoracic examination detects pleural and pericardial effusion. In the monitoring context, serial FAST examinations can detect developing effusions that indicate fluid overload before they become clinically apparent.

The technique is standardized and can be performed by non-radiologists after appropriate training. The four-point abdominal view and the thoracic views are rapid, repeatable, and do not require sedation in most patients. Serial examinations document the progression or resolution of effusions and guide the decision to reduce fluid rates or add diuretics.

Pulse Pressure Variation and Stroke Volume

Dynamic parameters such as pulse pressure variation and stroke volume variation predict fluid responsiveness more accurately than static parameters in mechanically ventilated patients. These measurements require an arterial catheter and either a dedicated monitor or an esophageal Doppler device. They are most reliable in patients receiving controlled ventilation with a regular cardiac rhythm and are not useful in spontaneously breathing patients or those with arrhythmias.

The equipment cost and technical expertise limit the use of these parameters in general practice. They are most valuable in referral settings where complex patients are managed and where the consequences of over-resuscitation are severe.

Monitoring Parameters and Action Thresholds

The table below summarizes the key monitoring parameters, recommended frequency, and action thresholds for over-hydration and under-hydration. Frequency should be increased during the resuscitation phase and decreased as the patient stabilizes.

The thresholds in this table are clinical decision points, not absolute values. A patient with pre-existing cardiac disease may show signs of fluid overload at a lower threshold than a healthy patient. A patient with ongoing hemorrhage may require a higher than normal fluid rate to maintain perfusion. The monitoring plan must be adjusted to the individual patient's physiology and disease process.

Species differences affect the interpretation of every parameter. Cats are more sensitive to fluid overload than dogs and develop pulmonary edema at lower volumes. Ruminants and horses have different reference ranges for many biochemical parameters and different responses to fluid therapy. Production animals may be monitored less intensively due to practical constraints, but the same physiological principles apply. The MSD Veterinary Manual provides species-specific reference ranges and clinical guidance for fluid therapy monitoring.

Documentation of monitoring findings should be structured and consistent. The flow sheet, whether paper or electronic, should include the time of each measurement, the value obtained, the fluid rate at that time, and any adjustments made. This record allows retrospective review of the resuscitation course and identifies patterns that might otherwise be missed. The AVMA practice resources offer guidance on medical record keeping standards that apply to fluid therapy monitoring.

Complications and Failure Modes of Fluid Therapy

Fluid therapy fails in two directions: under-resuscitation and over-resuscitation. Both carry distinct clinical signatures that monitoring must detect before irreversible injury occurs.

Volume overload is the most common iatrogenic complication in critically ill patients. It manifests as progressive weight gain exceeding 10% of admission weight, rising central venous pressure, peripheral edema, pulmonary crackles, and serous nasal discharge. The discriminating finding is a rising central venous pressure with a falling or static cardiac output, which distinguishes cardiogenic pulmonary edema from noncardiogenic causes such as acute respiratory distress syndrome. Daily weighing remains the most sensitive bedside tool, and intake-output charts that reconcile every milliliter administered against measured losses will identify positive balance before auscultatory changes appear.

Hyperchloraemic metabolic acidosis follows aggressive resuscitation with 0.9% sodium chloride. Serum chloride rises, strong ion difference falls, and base excess declines without concurrent lactate elevation. Detection requires paired electrolyte and blood gas analysis, not clinical examination alone. The corrective action is to switch to a balanced crystalloid, but the clinician must first confirm that the acidosis is not driven by hypoperfusion, which would mandate continued volume support.

Hypoglycemia and hyperglycemia both complicate critical illness. Hyperglycemia at the onset of cerebral ischemia worsens postischaemic neurologic outcome, and this risk extends to patients with cardiac arrest, severe hypotension, or thromboembolic stroke. Serial blood glucose measurement is therefore mandatory in any patient with suspected or ongoing cerebral ischemia, and fluid choice should account for dextrose content in neonates, small ruminants, and animals with hepatic dysfunction.

Transfusion-associated circulatory overload occurs when colloids or blood products are administered too rapidly in patients with marginal cardiac reserve. Rising jugular venous distension, tachypnoea, and a widening central venous pressure to pulmonary artery occlusion pressure gradient should trigger immediate cessation of the infusion and reassessment of the resuscitation end point.

Common Errors in Monitoring

Less experienced clinicians frequently mistake blood pressure for perfusion. A normotensive patient can still be under-resuscitated if lactate is rising, urine output is falling, or skin tenting persists. Conversely, a hypotensive patient may be adequately perfused if mentation, urine output, and lactate are normal. The corrective habit is to track trends across multiple parameters instead of reacting to single values.

A second error is discontinuing monitoring once the patient appears stable. The practice parameters for hemodynamic support of sepsis emphasize that clinicians should define specific goals and end points, titrate therapies to those end points, and evaluate results on an ongoing basis. Monitoring must continue until the patient is eating, drinking, and urinating normally, also until vital signs normalize.

A third error is ignoring the urinary catheter itself. An obstructed or kinked catheter produces a false oliguria that triggers inappropriate fluid boluses. The discriminating check is to flush the catheter, assess bladder size ultrasonographically, and measure the post-flush return before escalating therapy.

Students also over-rely on a single packed cell volume and total solids measurement. These values lag behind acute blood loss and are confounded by splenic contraction in dogs and by pre-existing anemia. Serial measurements, interpreted alongside lactate and blood pressure, provide the correct picture.

Evidence Limitations and Divergent Expert Opinion

The evidence base for fluid therapy monitoring in veterinary patients is largely extrapolated from human critical care. The 2004 sepsis hemodynamic support guidelines are explicitly human-focused, and their recommendations on end points such as central venous pressure targets have been contested in subsequent human trials. Veterinary studies validating specific monitoring thresholds in dogs, cats, and horses are sparse, and many protocols rest on physiologic first principles instead of outcome data.

Expert opinion diverges on the value of central venous pressure as a volume responsiveness indicator. Some clinicians still use it as a primary guide, while others regard it as useful only for detecting right heart failure or trends. Similarly, the role of point-of-care ultrasound in routine fluid monitoring is expanding, but the abdominal and thoracic focused assessment techniques were developed primarily for trauma triage, and their sensitivity for detecting clinically significant fluid overload in nontrauma critical illness is not fully characterized.

Glucose management in critical illness is another area of uncertainty. The recommendation to monitor glucose diligently in patients at risk for cerebral ischemia is well supported, but the optimal target range in veterinary patients is not established, and aggressive insulin therapy carries its own risks of hypoglycemia.

Escalation and Referral

Escalation is warranted when a patient fails to reach defined resuscitation end points despite appropriate fluid therapy, when invasive monitoring is required, or when complications exceed the capacity of the primary clinician.

Referral to a specialist criticalist or emergency service is appropriate for patients with persistent hypotension despite adequate volume resuscitation, rising lactate with normal vital signs, anuria or oliguria refractory to catheter correction, or suspected abdominal compartment syndrome. Specialist centers offer advanced hemodynamic monitoring, mechanical ventilation, and renal replacement therapy that are not available in general practice.

Laboratory involvement is indicated when acid-base disturbances are complex, when electrolyte abnormalities are refractory to correction, or when coagulopathy complicates fluid therapy. A diagnostic laboratory can provide serial blood gas analysis, coagulation panels, and electrolyte profiles that guide ongoing therapy.

Regulatory reporting obligations vary by jurisdiction. In production animal practice, fluid therapy complications that involve suspected adverse drug reactions, product defects, or unusual mortality patterns may require reporting to the relevant national pharmacovigilance authority. The World Organization for Animal Health terrestrial standards address disease surveillance and reporting obligations that may apply when fluid therapy is administered in the context of notifiable disease. Clinicians should consult their local veterinary board or professional practice resources for jurisdiction-specific requirements.

Frequently Asked Questions

How Do I Monitor Fluid Therapy When Advanced Monitoring Equipment Is Unavailable?

When Doppler blood pressure, central venous pressure, or ultrasound is unavailable, monitoring relies on serial physical examination, body weight, urine output, and laboratory values. Weigh the patient on the same scale at the same time daily, acute changes of more than 1 to 2 percent of body weight reflect fluid shifts instead of tissue gain or loss. Track packed cell volume and total solids every 4 to 6 hours during active resuscitation, as trends indicate hemodilution or hemoconcentration. Urine output can be estimated from litter box weight, cage bedding weight, or absorbent pad weight when catheterization is declined. Capillary refill time, mucous membrane moisture, skin turgor, and heart rate remain useful, but interpret them alongside perfusion parameters such as mentation and extremity temperature. Document every measurement so trends remain visible when technology is later introduced.

What Is the Minimum Acceptable Monitoring Frequency During Resuscitation Versus Maintenance?

During active resuscitation, reassess perfusion parameters every 15 to 30 minutes, including heart rate, pulse quality, mucous membrane color, capillary refill time, and blood pressure when available. Recheck packed cell volume, total solids, lactate, and acid-base status every 1 to 2 hours until the patient is hemodynamically stable. Once stabilized, reduce monitoring to every 4 to 6 hours for clinical parameters and daily for body weight, electrolytes, and renal values. Maintenance fluid therapy in stable patients warrants at least twice-daily clinical assessment and daily weight and urine output documentation. The 2004 sepsis guidelines emphasize defining specific goals and end points, then titrating therapy against those targets on an ongoing basis, instead of following a fixed schedule. Adjust frequency upward whenever a parameter trends away from the target range.

How Should I Adjust Monitoring for Cats Compared With Dogs?

Cats tolerate volume overload poorly and develop pulmonary edema at lower infusion volumes than dogs. Monitor cats with more frequent body weight measurements, ideally every 6 to 12 hours during fluid therapy, and auscult the lungs at each reassessment. Cats also mask hypovolemia with peripheral vasoconstriction, so a normal blood pressure reading does not exclude inadequate perfusion. Use serial lactate and urine output as corroborating evidence. Cats with chronic kidney disease may have fixed urine concentrating ability, making urine specific gravity an unreliable perfusion indicator, rely on urine volume trends instead. The MSD Veterinary Manual provides species-specific guidance on fluid therapy monitoring and interpretation of clinical parameters. In cats, err toward earlier escalation to advanced monitoring such as central venous pressure or thoracic ultrasound when response to initial resuscitation is incomplete.

What Should I Document in the Medical Record for Fluid Therapy Monitoring?

Record the fluid type, rate, and route at initiation and each change. Document serial body weight, urine output, blood pressure, heart rate, respiratory rate, packed cell volume, total solids, lactate, and electrolyte values with timestamps. Note estimated insensible losses and any vomiting, diarrhea, or drainage losses. Record the patient's attitude, appetite, and perfusion parameters at each assessment. Document the clinical rationale for rate adjustments, including the specific parameter that triggered the change. This record supports clinical decision-making and provides medicolegal protection. The AVMA practice resources offer guidance on medical record content and retention expectations for veterinary practice. A complete fluid balance chart should reconcile input against output at least daily, with discrepancies explained in the record.

How Do I Explain Fluid Therapy Monitoring to an Owner Who Is Concerned About Cost?

Explain that monitoring prevents the two most common complications of fluid therapy: under-resuscitation, which prolongs shock, and over-resuscitation, which causes fluid accumulation in the lungs or tissues. Frame each monitoring test as a check on a specific risk. For example, blood pressure measurement assesses perfusion adequacy, while serial weights detect fluid overload before it becomes clinically apparent. Offer a tiered plan: essential monitoring includes daily weight, urine output, and physical examination, advanced monitoring such as ultrasound or central venous pressure is added when the patient is unstable or not responding as expected. The Davis-Thompson Foundation pathology resources illustrate the tissue consequences of both under- and over-resuscitation, which can help owners understand why monitoring matters. Be transparent that reducing monitoring frequency lowers cost but increases risk of delayed detection of complications.

When Should I Refer the Patient for Advanced Hemodynamic Monitoring?

Refer or escalate when the patient fails to reach perfusion targets despite appropriate fluid resuscitation, when vasopressor or inotrope support is required, or when there is concern for fluid overload in a patient with cardiac or renal disease. Additional indications include persistent oliguria despite adequate perfusion, unexplained hypotension, or a rising lactate trend. Point-of-care ultrasound can be performed in general practice to assess for free fluid, cardiac filling, and lung ultrasound artefacts, and this technique has been standardized for veterinary emergency and critical care applications. If ultrasound is unavailable, refer when clinical parameters do not improve within 2 to 4 hours of resuscitation. Document the parameters that prompted referral and the therapies already administered, so the receiving clinician can continue monitoring without repeating interventions.

Related Clinical & Scientific Guides

• Hypersensitivity Reactions: Types and Mechanisms
• Therapeutic Decision-Making for Respiratory Infections in Cattle
• Monitoring Sedation and Anesthesia Recovery in Veterinary Patients

References and Further Reading

• Abdominal and thoracic focused assessment with sonography for trauma, triage, and monitoring in small animals.. 2011.
• Glucose modulation of ischemic brain injury: review and clinical recommendations.. 1996.
• Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease.. 2021.
• Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update.. 2004.
• Progress in the development and integration of fluid flow control tools in paper microfluidics.. 2017.
• Closed-loop and decision-assist resuscitation of burn patients.. 2008.
• Davis-Thompson Foundation Veterinary Pathology Resources. Davis-Thompson Foundation.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Monitoring Immunosuppressive Therapy in Veterinary Patients
• Monitoring Endocrine Therapy in Veterinary Patients: Insulin and Beyond
• Monitoring Analgesic Therapy in Horses: A Practical Guide
• Monitoring Corticosteroid Therapy in Veterinary Dermatology
• Decision Framework for Anticoagulant Therapy in Veterinary Patients

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.